Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Planned Donor Lymphocyte Infusion After Stem Cell Transplant
NCT01518153Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Feb 2012
- Primary completion
- Aug 2014
- Modality
- Allogeneic CAR-T, Tumor-Infiltrating Lymphocytes (TILs), TCR-Engineered T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of donor T-lymphocytes in leukemia, myelodysplastic syndrome (MDS), lymphoma, Hodgkin lymphoma (HL), multiple myeloma (MM), sponsored by University of Texas MD Anderson Cancer Center. Started Feb 2012; status: terminated.
02
Drugs
donor T-lymphocytes
03
Conditions
leukemiamyelodysplastic syndrome (MDS)lymphomaHodgkin lymphoma (HL)multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01518153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01518153.